http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-PA04004657-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10e4b1416c6e66e0ade5429212414964 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D257-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 |
| filingDate | 2002-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d64a2eeecb581d439cfb1c4be0cc932f |
| publicationDate | 2004-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | MX-PA04004657-A |
| titleOfInvention | FORMS AMORPHES AND CRYSTALS OF POTASSIUM OF LOSARTAN AND PROCESS FOR PREPARATION. |
| abstract | The invention relates to a novel amorphous losartan potassium, novel losartan potassium in a crystalline form that is a hydrate, the novel Form IV of losartan potassium crystalline and solvates thereof, the V form of novel and solvate crystalline losartan potassium of it, with processes for its preparation, with compositions that contain them and with their use in medicine. This invention also relates to a novel process for preparing Form I and Form II potassium of crystalline losartan. |
| priorityDate | 2001-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454025817 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663390 |
Total number of triples: 16.